Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III StudyLarry W. Kwak, Christian Buske, Michinori Ogura et al.|Clinical Lymphoma Myeloma & Leukemia|2021Cited by 14